In particular, When breast tumors were stratified into molecular subtypes, CCR7 expression in luminal (n = 566), HER2-positive (n = 37), triple-negative (n = 116) tumors was evidently higher than in noncancerous breast tissues (n = 114; Fig. 5H). Here, CCR7 is linked to breast neoplasm.